[Photo] Researchers Sweating It Out in COVID-19 Treatment Research View original image


Countries around the world are racing to develop vaccines and treatments to overcome the novel coronavirus disease (COVID-19). Korean bio venture company Engicam Life Sciences has received approval for a new drug substance from the U.S. Food and Drug Administration (FDA) and is conducting Phase 2 clinical trials. Ahead of the New Year 2021, a researcher is fully engaged in COVID-19 treatment research at Engicam Life Sciences' central research institute in Jecheon, Chungbuk./Jecheon=Reporter Kang Jinhyung aymsdream@



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing